Suppr超能文献

纯化Vi多糖伤寒疫苗的效力

Efficacy of purified Vi polysaccharide typhoid vaccine.

作者信息

Park Jong-Hwan, Hong Jung-Joo, Choi Eun-Sil, Lee Jin-Won, Park Jae-Hak

机构信息

Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Suwon 441-744, Korea.

出版信息

J Vet Sci. 2002 Jun;3(2):67-70.

Abstract

This experiment was conducted to assess the efficacy of typhoid vaccine newly produced by purifying Vi antigen of Salmonella typhi. With Karber method, LD50 of challenging organism (S. typhi ty2) was determined as 6.31 CFU/mouse, and then the organism was used for the study. With Probits method, ED50 of the vaccine was determined as 0.016 microg / 0.5 ml / mouse. The ELISA titer (0.5097+/-0.0606) was 4 times in the group treated with high dose (0.25 microg/0.5ml) as in control (0.1113+/-0.0110). Six major protein bands of 66, 55, 35, 33, 18, and 9 kd were detected in Western blot analysis with serum of a vaccine treated mouse, whereas only one weak band of about 35 kd was detected with serum of a control mouse. We concluded that typhoid vaccine produced by purifying Vi antigen of S. typhi very effectively prevent S. typhi infection in mice.

摘要

本实验旨在评估通过纯化伤寒沙门菌Vi抗原新生产的伤寒疫苗的效力。采用寇氏法测定攻击菌(伤寒杆菌ty2)的半数致死量(LD50)为6.31CFU/只小鼠,然后将该菌用于研究。采用概率单位法测定疫苗的半数有效量(ED50)为0.016μg/0.5ml/只小鼠。高剂量(0.25μg/0.5ml)处理组的ELISA效价(0.5097±0.0606)是对照组(0.1113±0.0110)的4倍。用疫苗处理小鼠的血清进行Western印迹分析,检测到66、55、35、33、18和9kd的6条主要蛋白带,而用对照小鼠的血清仅检测到一条约35kd的弱带。我们得出结论,通过纯化伤寒沙门菌Vi抗原生产的伤寒疫苗能非常有效地预防小鼠感染伤寒杆菌。

相似文献

3
Vi Capsular Polysaccharide Produced by Recombinant Serovar Paratyphi A Confers Immunoprotection against Infection by Serovar Typhi.
Front Cell Infect Microbiol. 2017 Apr 24;7:135. doi: 10.3389/fcimb.2017.00135. eCollection 2017.
4
A Salmonella typhi Vi conjugate vaccine.
N Engl J Med. 2001 Aug 16;345(7):545-6. doi: 10.1056/NEJM200108163450713.
6
Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
J Infect Dis. 1984 Sep;150(3):436-49. doi: 10.1093/infdis/150.3.436.
9
Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assay.
J Med Microbiol. 2013 Feb;62(Pt 2):283-286. doi: 10.1099/jmm.0.047159-0. Epub 2012 Oct 25.
10
Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
Expert Rev Vaccines. 2007 Jun;6(3):293-5. doi: 10.1586/14760584.6.3.293.

引用本文的文献

1
Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
Vaccine. 2017 Dec 18;35(51):7121-7126. doi: 10.1016/j.vaccine.2017.10.081. Epub 2017 Nov 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验